The Prescription trends and dosing appropriateness analysis of novel oral anticoagulants in ischemic stroke patients: a retrospective study of 9 cities in China
Background: Novel oral anticoagulants (NOACs) have been recommended by guidelines as the first-line drugs for preventing cardiogenic stroke. We aimed to provide an overview of the prescription trends and dosing appropriateness of NOACs in China.Methods: We conducted a retrospective analysis of NOAC...
Main Authors: | Mingfen Wu, Hailun Jiang, Kefu Yu, Zhigang Zhao, Bin Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1304139/full |
Similar Items
-
Prescriptive behavior of non-vitamin K oral anticoagulants in patients affected by atrial fibrillation in general practice
by: M. Rottura, et al.
Published: (2023-09-01) -
Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants
by: Jo-Nan Liao, et al.
Published: (2022-07-01) -
Anticoagulation stewardship: Descriptive analysis of a novel approach to appropriate anticoagulant prescription
by: Maral Koolian, et al.
Published: (2022-08-01) -
Non-Vitamin K Antagonist Oral Anticoagulants versus Low Molecular Weight Heparin for Cancer-Related Venous Thromboembolic Events: Individual Patient Data Meta-Analysis
by: Chun En Yau, et al.
Published: (2023-12-01) -
Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)